vs
Side-by-side financial comparison of ADMA BIOLOGICS, INC. (ADMA) and ONE Group Hospitality, Inc. (STKS). Click either name above to swap in a different company.
ONE Group Hospitality, Inc. is the larger business by last-quarter revenue ($207.0M vs $139.2M, roughly 1.5× ADMA BIOLOGICS, INC.). ADMA BIOLOGICS, INC. runs the higher net margin — 35.5% vs -3.1%, a 38.6% gap on every dollar of revenue. On growth, ADMA BIOLOGICS, INC. posted the faster year-over-year revenue change (18.4% vs -6.7%). ADMA BIOLOGICS, INC. produced more free cash flow last quarter ($34.6M vs $-329.0K). Over the past eight quarters, ONE Group Hospitality, Inc.'s revenue compounded faster (56.1% CAGR vs 30.4%).
ADMA Biologics Inc. is a biopharmaceutical enterprise focused on the research, development, manufacturing and commercialization of specialty plasma-derived immunoglobulin therapies. It primarily operates in the United States, catering to patients with primary immunodeficiency and other immune-related disorders, healthcare providers and medical institutions across its core immune health therapeutic segment.
Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.
ADMA vs STKS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $139.2M | $207.0M |
| Net Profit | $49.4M | $-6.4M |
| Gross Margin | 63.8% | — |
| Operating Margin | 45.1% | 2.2% |
| Net Margin | 35.5% | -3.1% |
| Revenue YoY | 18.4% | -6.7% |
| Net Profit YoY | -55.9% | -531.8% |
| EPS (diluted) | $0.20 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $139.2M | $207.0M | ||
| Q3 25 | $134.2M | $180.2M | ||
| Q2 25 | $122.0M | $207.4M | ||
| Q1 25 | $114.8M | $211.1M | ||
| Q4 24 | $117.5M | $221.9M | ||
| Q3 24 | $119.8M | $194.0M | ||
| Q2 24 | $107.2M | $172.5M | ||
| Q1 24 | $81.9M | $85.0M |
| Q4 25 | $49.4M | $-6.4M | ||
| Q3 25 | $36.4M | $-76.7M | ||
| Q2 25 | $34.2M | $-10.1M | ||
| Q1 25 | $26.9M | $975.0K | ||
| Q4 24 | $111.9M | $1.5M | ||
| Q3 24 | $35.9M | $-9.3M | ||
| Q2 24 | $32.1M | $-7.3M | ||
| Q1 24 | $17.8M | $-2.1M |
| Q4 25 | 63.8% | — | ||
| Q3 25 | 56.3% | — | ||
| Q2 25 | 55.1% | — | ||
| Q1 25 | 53.2% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 49.8% | — | ||
| Q2 24 | 53.6% | — | ||
| Q1 24 | 47.8% | — |
| Q4 25 | 45.1% | 2.2% | ||
| Q3 25 | 38.0% | -4.4% | ||
| Q2 25 | 35.1% | 0.3% | ||
| Q1 25 | 30.4% | 5.1% | ||
| Q4 24 | 32.6% | 5.5% | ||
| Q3 24 | 33.1% | -1.9% | ||
| Q2 24 | 36.6% | 0.6% | ||
| Q1 24 | 26.7% | -0.7% |
| Q4 25 | 35.5% | -3.1% | ||
| Q3 25 | 27.1% | -42.6% | ||
| Q2 25 | 28.1% | -4.9% | ||
| Q1 25 | 23.4% | 0.5% | ||
| Q4 24 | 95.2% | 0.7% | ||
| Q3 24 | 30.0% | -4.8% | ||
| Q2 24 | 29.9% | -4.3% | ||
| Q1 24 | 21.7% | -2.4% |
| Q4 25 | $0.20 | $-0.50 | ||
| Q3 25 | $0.15 | $-2.75 | ||
| Q2 25 | $0.14 | $-0.59 | ||
| Q1 25 | $0.11 | $-0.21 | ||
| Q4 24 | $0.45 | $-0.18 | ||
| Q3 24 | $0.15 | $-0.53 | ||
| Q2 24 | $0.13 | $-0.38 | ||
| Q1 24 | $0.08 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $87.6M | $4.2M |
| Total DebtLower is stronger | $72.1M | $354.2M |
| Stockholders' EquityBook value | $477.3M | $-75.8M |
| Total Assets | $624.2M | $884.2M |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.6M | $4.2M | ||
| Q3 25 | $61.4M | $5.5M | ||
| Q2 25 | $90.3M | $4.7M | ||
| Q1 25 | $71.6M | $21.4M | ||
| Q4 24 | $103.1M | $27.6M | ||
| Q3 24 | $86.7M | $28.2M | ||
| Q2 24 | $88.2M | $32.2M | ||
| Q1 24 | $45.3M | $15.4M |
| Q4 25 | $72.1M | $354.2M | ||
| Q3 25 | $72.4M | $355.0M | ||
| Q2 25 | — | $347.4M | ||
| Q1 25 | — | $348.3M | ||
| Q4 24 | $72.3M | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M | ||
| Q1 24 | — | $73.5M |
| Q4 25 | $477.3M | $-75.8M | ||
| Q3 25 | $431.2M | $-61.5M | ||
| Q2 25 | $398.3M | $23.0M | ||
| Q1 25 | $373.4M | $40.5M | ||
| Q4 24 | $349.0M | $45.9M | ||
| Q3 24 | $231.9M | $51.4M | ||
| Q2 24 | $188.3M | $68.1M | ||
| Q1 24 | $153.7M | $68.3M |
| Q4 25 | $624.2M | $884.2M | ||
| Q3 25 | $568.7M | $879.5M | ||
| Q2 25 | $558.4M | $935.7M | ||
| Q1 25 | $510.6M | $956.0M | ||
| Q4 24 | $488.7M | $960.1M | ||
| Q3 24 | $390.6M | $953.5M | ||
| Q2 24 | $376.4M | $945.9M | ||
| Q1 24 | $350.9M | $309.3M |
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | — | 15.07× | ||
| Q1 25 | — | 8.61× | ||
| Q4 24 | 0.21× | 7.59× | ||
| Q3 24 | — | 6.79× | ||
| Q2 24 | — | 5.14× | ||
| Q1 24 | — | 1.08× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.6M | $13.1M |
| Free Cash FlowOCF − Capex | $34.6M | $-329.0K |
| FCF MarginFCF / Revenue | 24.8% | -0.2% |
| Capex IntensityCapex / Revenue | 0.8% | 6.5% |
| Cash ConversionOCF / Net Profit | 0.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $27.8M | $-27.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.6M | $13.1M | ||
| Q3 25 | $13.3M | $5.9M | ||
| Q2 25 | $21.1M | $2.8M | ||
| Q1 25 | $-19.7M | $8.5M | ||
| Q4 24 | $50.2M | $18.5M | ||
| Q3 24 | $25.0M | $19.1M | ||
| Q2 24 | $45.6M | $-3.8M | ||
| Q1 24 | $-2.2M | $10.4M |
| Q4 25 | $34.6M | $-329.0K | ||
| Q3 25 | $-1.1M | $-6.1M | ||
| Q2 25 | $18.7M | $-15.0M | ||
| Q1 25 | $-24.4M | $-5.8M | ||
| Q4 24 | $47.5M | $733.0K | ||
| Q3 24 | $24.0M | $287.0K | ||
| Q2 24 | $43.6M | $-23.0M | ||
| Q1 24 | $-4.6M | $-5.4M |
| Q4 25 | 24.8% | -0.2% | ||
| Q3 25 | -0.8% | -3.4% | ||
| Q2 25 | 15.3% | -7.2% | ||
| Q1 25 | -21.2% | -2.7% | ||
| Q4 24 | 40.4% | 0.3% | ||
| Q3 24 | 20.0% | 0.1% | ||
| Q2 24 | 40.7% | -13.3% | ||
| Q1 24 | -5.6% | -6.4% |
| Q4 25 | 0.8% | 6.5% | ||
| Q3 25 | 10.7% | 6.7% | ||
| Q2 25 | 2.0% | 8.6% | ||
| Q1 25 | 4.1% | 6.8% | ||
| Q4 24 | 2.3% | 8.0% | ||
| Q3 24 | 0.9% | 9.7% | ||
| Q2 24 | 1.9% | 11.1% | ||
| Q1 24 | 2.9% | 18.6% |
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | -0.73× | 8.76× | ||
| Q4 24 | 0.45× | 12.54× | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | -0.12× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
STKS
| Benihanas | $111.3M | 54% |
| Steakhouse Restaurant | $59.2M | 29% |
| Grill Concepts | $32.3M | 16% |
| Other | $4.2M | 2% |
